INNOVITA BIOLOGICAL TECHNOLOGY revenue breakdown overview

INNOVITA BIOLOGICAL TECHNOLOGY revenue for the last year amounted to 478.00 M CNY, the most of which — 405.49 M CNY — came from its highest performing source at the moment, Respiratory Tract Series - Non-COVID-19 Products. The greatest contribution to the revenue figure was made by China — last year it brought INNOVITA BIOLOGICAL TECHNOLOGY 464.96 M CNY, and the year before that — 420.95 M CNY.